Factors associated with vitamin D deficiency in a population of 2044 HIV-infected patients

Clinical Nutrition

Volumn 33, Issue 2, 2014, Pages 274-279

  Theodorou, Maria ^a   Sersté, Thomas ^a   Van Gossum, Marc ^a   Dewit, Stéphane ^a  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Antiretroviral therapy; Associated factors; HIV; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; EFAVIRENZ;

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; FEMALE; GENDER; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; TREATMENT DURATION; VERY ELDERLY; VIRUS LOAD; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; WINTER; YOUNG ADULT;

ANTIRETROVIRAL THERAPY; ASSOCIATED FACTORS; HIV; VITAMIN D;

ADULT; AGED; AGED, 80 AND OVER; BENZOXAZINES; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; VIRAL LOAD; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84895420847     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2013.04.018     Document Type: Article

References (29)

1. Bischoff-Ferrari H.A., Dietrich T., Orav E.J., Dawson-Hughes B. Positive association between 25-hdroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 2004, 116:634-639.
2. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., Giovannucci E., Dietrich T., Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005, 293:2257-2264.
3. Etten Van, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem. Mol Biol 2005, 97:93-101.
4. Rosen C.J. Clinical practice. Vitamin D insufficiency. N Engl J Med 2011, 364:248-254.
5. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., Dietrich T., Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006, 84:18-28.
6. Holick M.F. Vitamin D deficiency. N Engln J Med 2007, 357:266-281.
7. Heany R.P. The vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 2005, 97:13-19.
8. Steingrimsdottir L., Gunnarsson O., Indridason O.S., Franzson L., Sigurdsson G. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 2005, 294:2336-2341.
9. Villamor E. A potential role for vitamin D on HIV infection?. Nutr Rev 2006, 64:226-233.
10. Viard J.P., Souberbielle J.C., Kirk O., Reekie J., Knysz B., Losso M., et al. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study. AIDS 2011, 25(10):1305-1315.
11. Mueller N.J., Fux C.A., Ledergerber B., Elzi L., Schmid P., Dang T., Magenta L., et al. High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naïve and successfully treated Swiss HIV patients. AIDS 2010, 24:1127-1134.
12. Crutchley R.D., Gathe J., Mayberry C., Trieu A., Abughosh S., Garey K.W. Risk factors for vitamin D deficiency in HIV-infected patients in the south central United States. AIDS Res Hum Retroviruses 2012, 28(5):454-459.
13. Van Den Bout-Van Den Beukel C.J., Fievez L., Michels M., Sweep F.C., Hermus A.R., Bosch M.E., et al. Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. Aids Res Hum Retrovirus 2008, 24:1375-1382.
14. Dao C.N., Patel P., Overton E.T., Rhame F., Pals S.L., Johnson C., et al. Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin Infect Dis 2011, 52:396-405.
15. Welz T., Childs K., Ibrahim F., Poulton M., Taylor C.B., Moniz C.F., et al. Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase. AIDS 2010, 24(12):1923-1928.
16. Brown T.T., McComsey G.A. Association between initiation of antiretroviral therapy with Efavirenz and decreases in 25-Hydroxyvitamin D. Antivir Ther 2010, 15:425-429.
17. Stein E.M., Yin M.T., McMahon D.J., Shu A., Zhang C.A., Ferris D.C., et al. Vitamin D deficiency in HIV-infected postmenopausal Hispanic and African-American women. Osteoporos Int 2011 Feb, 22(2):477-487.
18. Kim J.H., Gandhi V., Psevdos G., Espinoza F., Park J., Sharp V. Evaluation of vitamin D levels among HIV-infected patients in New York city. AIDS Res Hum Retroviruses 2012, 28(3):235-241.
19. Mehta S., Giovannucci E., Mugusi F.M., Spiegelman D., Aboud S., Hertzmark E., et al. Vitamin D status of HIV-infected women and its association with HIV disease progression, anémia, and mortality. PLoS One 2010, 5(1):8770.
20. Mehta S., Mugusi F.M., Spiegelman D., Villamor E., Finkelstein J.L., Hertzmark E., et al. Vitamin D status and its association with morbidity including wasting and opportunistic illnesses in HIV-infected women in Tanzania. AIDS Patient Care STDS 2011, 25(10):579-585.
21. Knobel H., Guelar A., Vallecillo G., Nogués X., Díez A. Osteopenia in HIV-infected patients. Is it the disease or is it the treatment. AIDS 2001, 15(6):807-808.
22. Libois A., Clumeck N., Kabeya K., Gerard M., De Wit S., Poll B., et al. Risk factor of osteopenia in HIV-infected women: no role of antiretroviral therapy. Maturitas 2010 Jan, 65:51-54.
23. Haug C.J., Aukrust P., Haug E., Mørkrid L., Müller F., Frøland S.S. Severe deficiency of 1.25 dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis. J Clin Endocrin Metab 1998, 83:3832-3838.
24. Gal-Tanamy M., Bachmetov L., Ravid A., Koren R., Erman A., Tur R., et al. Vitamin D: an innate antiviral agent suppressing Hepatitis C virus in human Hepatocytes. Hepatology 2011, 54:1570-1579.
25. Jenab M., Bueno-de-Mesquita H.B., Ferrari P., van Duijnhoven F.J., Norat T., Pischon T., et al. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case-control study. BMJ 2010, 340:b5500.
26. Pfeifer M., Begerow B., Minne H.W., Nachtigall D., Hansen C. Effects of a short-term Vitamin D (3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001, 86:1633-1637.
27. Martins D., Wolf M., Pan D., Zadshir A., Tareen N., Thadhani R., et al. Prevalence of cardiovascular risk factors and the serum levels of 25-Hydroxyvitamin D in the United States. Arch Intern Med 2007, 167:1159-1165.
28. Wang T.J., Pencina M.J., Booth S.L., Jacques P.F., Ingelsson E., Lanier K., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117:503-511.
29. Wang T.J., Pencina M.J., Booth S.L., Jacques P.F., Ingelsson E., Lanier K., et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med 2010, 170:1135-1141.